Skip to content
healthcare.dev

Nevirapine

NDC 65162-209, Nevirapine, tablet, from Amneal Pharmaceuticals LLC.

Product NDC
65162-209
Status
Listed
Labeler
Amneal Pharmaceuticals LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA078195
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65162-209 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NEVIRAPINE200 mg/1

Pharmacologic classes

Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 3A Inducers [MoA]; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Non-Nucleoside Analog [EXT]; Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]

Package NDCNDC-11Package
65162-209-066516202090660 TABLET in 1 BOTTLE (65162-209-06)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4f065674-4719-4c79-ba0d-549040d77f17

Use it

Look up 65162-209 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65162-209 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65162-209. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.